Sobi and Novimmune have secured approval from the US Food and Drug Administration (FDA) for Gamifant (emapalumab-lzsg), the first and only treatment indicated for Primary Hemophagocytic Lymphohistiocytosis (HLH).
21 November 2018 News
20 November 2018 Deal News
Iceland-based Alvotech has signed a deal for commercialisation of its biosimilar portfolio in Japan in an exclusive partnership agreement with Fuji Pharma.
29 June 2018 projects
Boehringer Ingelheim is developing a new biologicals development centre (BDC) within its Biberach plant site in Germany.
23 March 2018 projects
In October 2017, Janssen Sciences Ireland began constructing an expansion of its biologics manufacturing facility in Ringaskiddy, County Cork, Ireland.
22 March 2018 projects
The Biomedical Engineering and Advanced Manufacturing (BEAM) centre is located in McMaster Innovation Park in Hamilton, Ontario, Canada.
19 January 2018 projects
Colorado State University (CSU) began construction of the C. Wayne McIlwraith Translational Medicine Institute (TMI) in June 2017.
16 January 2018 projects
Leading Switzerland-based biopharmaceuticals supplier Lonza and French life sciences firm Sanofi has established a joint venture (JV) to set up a large-scale biologics production facility in Visp, Switzerland.
13 November 2017 projects
Boehringer Ingelheim has broken ground on a $217m expansion of its Fremont facility in California, US.
10 August 2017 projects
The University of Southampton’s Centre of Cancer Immunology is currently under construction at Southampton General Hospital site, located adjacent to the Somers Building, and will be the first and only...